Table 1.
Tumor characteristics and patient demographics
| Characteristics | Case 1 | Case 2 | Case 3 | Case 4 |
|---|---|---|---|---|
| Age | 56 | 48 | 44 | 75 |
| Sex | Female | Female | Male | Female |
| Basal dimension, mm | 11.5X9 | 10X12 | 14X10 | 10×8 |
| Thickness, mm | 5 | 6 | 4.4 | Not known |
| Retinal invasion | No | No | No | No |
| Vitreous/subretinal pigment prior to plaque brachytherapy | No | No | No | No |
| Tumor biopsy | No | No | No | No |
| Treatment | I-125 plaque | I-125 plaque | I-125 plaque | I-125 plaque |
| brachytherapy + TTT | brachytherapy + TTT | brachytherapy | brachytherapy | |
| Duration from treatment to appearance of pigment dispersion, months | 120 | 44 | 24 | 36 |
| Location of pigment dispersion | Subretinal + intravitreal | Subretinal + intravitreal | Intravitreal | Overlying retina |
| Diagnostic vitrectomy | No | No | Yes | No |
| Follow-up since primary treatment, months | 144 | 70 | 104 | 343 |
| Follow-up since pigment dispersion, months | 26 | 26 | 80 | 307 |
| Visual acuity at last visit | 20/40 | 20/80 | 20/60 | No LP |
| Tumor recurrence at last visit | None | None | None | None |
| Systemic status at last visit | None | None | None | None |